• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Kidney Infection Market Share

    ID: MRFR/LS/3754-HCR
    110 Pages
    Kinjoll Dey
    September 2025

    Kidney Infection Market Research Report Information By Diagnosis (Dipstick Urine Test, Imaging Test, Treatment (Medication, Antibiotics, Nsaids, Dialysis, Kidney Transplant), End User (Hospitals & Clinics, Nephrology Center, Research Institutes) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Kidney Infection Market Research Report - Forecast till 2032 Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Kidney Infection Market Share Analysis

    Effectively positioning in the effective market starts kidney infection This includes reading the superiority of kidney infections, affected person demographics, and the aggressive panorama to discover possibilities and demanding situations. Given the susceptibility of certain demographics to kidney infections, a focused approach is crucial. Identifying excessive-risk organizations, inclusive of individuals with pre-current conditions or compromised immune structures, allows agencies to tailor their techniques to cope with the unique needs of these segments. Differentiating inside the Kidney infection market calls for a dedication to innovation. Investing in the development of novel treatment options, whether via new drug formulations, healing processes, or advanced medical technologies, can set an agency apart and entice healthcare specialists and sufferers. Pricing strategies play a pivotal role in market share positioning, mainly in the healthcare sector. Striking a balance between profitability and affordability is vital. Making remedies cost-effective and reachable contributes now not only to the market percentage boom but also to public fitness projects. Given the crucial nature of kidney infections, adherence to stringent regulatory requirements and exceptional guarantees is paramount. Companies have to invest in sturdy regulatory compliance measures to ensure the safety and efficacy of their products, constructing consideration amongst healthcare experts and sufferers alike. Embracing digital fitness solutions and telemedicine can revolutionize patient care in the Kidney infection market. Integrating technologies that enable remote tracking, consultations, and records-driven insights can improve patient outcomes even as the expanding market grows. Establishing a robust logo presence is fundamental to market percentage positioning. Implementing powerful advertising techniques, along with online and offline channels, can beautify brand visibility and popularity. This, coupled with a high-quality brand picture, contributes to a market boom and the establishment of a devoted customer base. The Kidney infection market, like every other healthcare sector, is concerned with steady evolution. Companies have to remain adaptable to emerging tendencies, whether in treatment modalities, healthcare policies, or technological advancements, to live ahead of the curve and keep a competitive part in the market.

    Market Summary

    The Global Kidney Infection Market is projected to grow significantly from 4.79 USD Billion in 2024 to 16.0 USD Billion by 2035.

    Key Market Trends & Highlights

    Kidney Infection Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 11.6% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 16.0 USD Billion, reflecting robust growth.
    • In 2024, the market is valued at 4.79 USD Billion, indicating a strong foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing prevalence of kidney infections is a major market driver.

    Market Size & Forecast

    2024 Market Size 4.79 (USD Billion)
    2035 Market Size 16.0 (USD Billion)
    CAGR (2025-2035) 11.6%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    AbbVie, Inc. (U.S.), Allergan plc. (U.K), Amgen Inc. (U.S.), AstraZeneca (U.K), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), Johnson & Johnson Services Inc. (U.S.), Keryx Biopharmaceuticals, Inc. (U.S.), Kissei Pharmaceutical Co. Ltd. (Japan), Pfizer (U.S.), Sanofi (France), Teva Pharmaceutical Industries Ltd. (Japan)

    Market Trends

    The increasing prevalence of kidney infections, coupled with a growing awareness of preventive healthcare measures, appears to be driving a notable shift in treatment approaches and patient management strategies.

    Centers for Disease Control and Prevention (CDC)

    Kidney Infection Market Market Drivers

    Market Growth Projections

    The Global Kidney Infection Market Industry is projected to experience substantial growth over the next decade. With a market value of 4.79 USD Billion in 2024, it is anticipated to reach 16.0 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 11.6% between 2025 and 2035. Such projections reflect the increasing demand for effective treatments and diagnostics in managing kidney infections. The market dynamics are influenced by various factors, including rising incidence rates, advancements in technology, and growing healthcare investments, all contributing to a robust future for the industry.

    Rising Healthcare Expenditure

    The global increase in healthcare expenditure is likely to bolster the Global Kidney Infection Market Industry. As nations prioritize healthcare spending, particularly in developing regions, access to medical services and treatments for kidney infections improves. This trend is evident in various countries where investments in healthcare infrastructure are made to enhance patient care. The anticipated compound annual growth rate of 11.6% from 2025 to 2035 indicates a robust market response to these investments. Enhanced funding for research and development in nephrology may also lead to innovative treatment options, further driving market growth.

    Emergence of Novel Therapeutics

    The introduction of novel therapeutics for kidney infections is poised to significantly impact the Global Kidney Infection Market Industry. Recent advancements in pharmacology have led to the development of new antibiotics and treatment regimens that are more effective against resistant strains of bacteria. This evolution in treatment options is crucial, given the rising concern over antibiotic resistance. As healthcare providers adopt these innovative therapies, patient outcomes are expected to improve, thereby increasing market demand. The ongoing research into targeted therapies may also play a role in shaping the future landscape of kidney infection management.

    Growing Awareness and Education

    Increased awareness and education regarding kidney health and infections are pivotal to the expansion of the Global Kidney Infection Market Industry. Public health campaigns and educational initiatives by healthcare organizations aim to inform individuals about the symptoms and risks associated with kidney infections. This heightened awareness encourages early medical consultation, leading to increased diagnosis and treatment rates. As a result, the market is expected to witness substantial growth, with projections indicating a rise to 16.0 USD Billion by 2035. The focus on preventive measures and lifestyle modifications may further contribute to this trend, emphasizing the importance of kidney health.

    Rising Incidence of Kidney Infections

    The increasing prevalence of kidney infections globally appears to be a primary driver for the Global Kidney Infection Market Industry. Factors such as the rise in urinary tract infections, which can lead to kidney infections, contribute significantly to this trend. In 2024, the market is projected to reach 4.79 USD Billion, reflecting heightened awareness and diagnosis of kidney-related ailments. This surge is likely influenced by lifestyle changes, urbanization, and an aging population, all of which may exacerbate the incidence of these infections. As healthcare systems adapt to these challenges, the demand for effective treatment options is expected to grow.

    Advancements in Diagnostic Technologies

    Technological innovations in diagnostic tools are transforming the landscape of the Global Kidney Infection Market Industry. Enhanced imaging techniques, such as ultrasound and CT scans, enable earlier and more accurate detection of kidney infections. These advancements not only facilitate timely treatment but also improve patient outcomes. The integration of artificial intelligence in diagnostics may further streamline processes, potentially reducing the time to diagnosis. As these technologies become more accessible, healthcare providers are likely to adopt them, thereby driving market growth. The emphasis on precision medicine underscores the importance of these advancements in managing kidney infections.

    Market Segment Insights

    Regional Insights

    Key Companies in the Kidney Infection Market market include

    Industry Developments

    Future Outlook

    Kidney Infection Market Future Outlook

    The Global Kidney Infection Market is projected to grow at 11.6% CAGR from 2024 to 2035, driven by rising prevalence, advancements in diagnostics, and increased healthcare spending.

    New opportunities lie in:

    • Develop innovative antibiotic therapies targeting resistant strains.
    • Leverage telemedicine for remote patient monitoring and management.
    • Invest in AI-driven diagnostic tools for early detection and treatment optimization.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment and increased awareness.

    Market Segmentation

    Kidney Infection Market Segmentations

    Kidney Infection Market Key Players
    • AbbVie, Inc. (U.S.)
    • Allergan plc. (U.K)
    • Amgen Inc. (U.S.)
    • AstraZeneca (U.K)
    • F. Hoffmann-La Roche Ltd (Switzerland)
    • GlaxoSmithKline plc. (U.K)
    • Johnson & Johnson Services Inc. (U.S.)
    • Keryx Biopharmaceuticals, Inc. (U.S.)
    • Kissei Pharmaceutical Co. Ltd. (Japan)
    • Pfizer (U.S.)
    • Sanofi (France)
    • Teva Pharmaceutical Industries Ltd. (Japan)

    Report Scope

    Attribute/Metric Details
    Market Size 2023 4.4 (USD Billion)
    Market Size 2024 4.79 (USD Billion)
    Market Size 2032 10.67 (USD Billion)
    Compound Annual Growth Rate (CAGR) 14.5 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
    Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
    Key Vendors AbbVie, Inc. (U.S.), Allergan plc. (U.K), Amgen Inc. (U.S.), AstraZeneca (U.K), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), Johnson & Johnson Services Inc. (U.S.), Keryx Biopharmaceuticals, Inc. (U.S.), Kissei Pharmaceutical Co. Ltd. (Japan), Pfizer (U.S.), Sanofi (France), Teva Pharmaceutical Industries Ltd. (Japan), and others
    Key Market Opportunities New product launches and R&D Amongst major key Players
    Key Market Drivers Increasing prevalence of kidney infections Increasing investment by biotechnology and pharmaceutical industries in R&D Rising need for the better treatment methods

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What would be the kidney infection market CAGR during the forecast period (2022-2030)?

    The kidney infection market CAGR would be 14.5% CAGR during the forecast period.

    What are the end users included in the kidney infection market report?

    The end users mentioned in the report are hospitals & clinics, nephrology centers, research centers, and others.

    Which region would lead the kidney infection market?

    The Americas would dominate the global kidney infection market.

    Which region would be the fastest-growing kidney infection market?

    The Asia Pacific kidney infection market would lead the global market in terms of CAGR.

    What could hold back the kidney infection market?

    High treatment cost and diving productivity can hamper the kidney infection market prospect.

    1. 'Table of Content
    2. Report Prologue
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
    5. Introduction
      1. Primary Research
      2. Secondary research
      3. Market
    6. Size Estimation
    7. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
    8. Technology Trends & Assessment
    9. Market Factor Analysis
      1. Porters
    10. Five Forces Analysis
      1. Bargaining Power of Suppliers
        1. Bargaining
    11. Power of Buyers
      1. Threat of New Entrants
        1. Threat of Substitutes
        2. Intensity of Rivalry
      2. Value Chain Analysis
      3. Investment
    12. Feasibility Analysis
      1. Pricing Analysis
    13. Global Kidney Infection
    14. Market, by Diagnosis
      1. Introduction
      2. Dipstick Urine Test
    15. Market Estimates & Forecast, 2020-2027
      1. Imaging Test
        1. Market
    16. Estimates & Forecast, 2020-2027
      1. Others
        1. Market Estimates
    17. & Forecast, 2020-2027
    18. Global Kidney Infection Market, by Treatment
      1. Introduction
      2. Medication
        1. Market Estimates & Forecast,
      3. Dialysis
        1. Market Estimates & Forecast, 2020-2027
      4. Kidney Transplant
        1. Market Estimates & Forecast, 2020-2027
      5. Others
        1. Market Estimates & Forecast, 2020-2027
    19. Global
    20. Kidney Infection Market, by End User
      1. Introduction
      2. Hospital &
    21. Clinics
      1. Market Estimates & Forecast, 2020-2027
      2. Nephrology
    22. Centers
      1. Market Estimates & Forecast, 2020-2027
      2. Research
    23. Institutes
      1. Market Estimates & Forecast, 2020-2027
      2. Others
        1. Market Estimates & Forecast, 2020-2027
    24. Global Kidney Infection
    25. Market, by Region
      1. Introduction
      2. Americas
        1. North America
        2. South America
      3. Europe
    26. Western Europe
      1. Germany
        1. France
    27. Italy
      1. Spain
        1. Rest of Western Europe
        2. Eastern
    28. Europe
      1. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic of Korea
        6. Rest of Asia Pacific
      2. The Middle East & Africa
        1. United Arab Emirates
        2. Saudi
    29. Arabia
      1. Oman
        1. Kuwait
        2. Qatar
        3. Rest of the
    30. Middle East & Africa
    31. Company Landscape
      1. Introduction
    32. Market Share Analysis
      1. Key Development & Strategies
        1. Key
    33. Developments
    34. Company Profiles
      1. AbbVie, Inc.
        1. Company
    35. Overview
      1. Product Overview
        1. Financials
      2. Allergan
    36. plc.
      1. Company Overview
        1. Product Overview
        2. Financial
    37. Overview
      1. Key Developments
      2. Amgen Inc.
        1. Company
    38. Overview
      1. Product Overview
        1. Financial Overview
    39. Key Development
      1. AstraZeneca
        1. Company Overview
    40. Product/Business Segment Overview
      1. Financial Overview
        1. Key
    41. Development
      1. F. Hoffmann-La Roche Ltd
        1. Company Overview
        2. Product Overview
        3. Financial overview
        4. Key Developments
      2. GlaxoSmithKline plc.
        1. Company Overview
        2. Product
    42. Overview
      1. Financial Overview
        1. Key Developments
    43. Johnson & Johnson Services Inc.
      1. Overview
        1. Product Overview
        2. Financials
        3. Key Developments
      2. Others
    44. MRFR Conclusion
      1. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs of the Market
      2. Key Companies to Watch
    45. Prediction of Kidney Infection Industry
    46. Appendix
    47. Kidney Infection Market Estimates and Forecast, 2020-2027, (USD Million)
    48. Global Kidney Infection Market by Region, 2020-2027, (USD Million)
    49. Global Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
    50. Global Kidney Infection Market by Treatment, 2020-2027, (USD Million)
    51. Global Kidney Infection Market by End Users, 2020-2027, (USD Million)
    52. North America Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
    53. Million)
    54. (USD Million)
    55. 2027, (USD Million)
    56. Diagnosis, 2020-2027, (USD Million)
    57. Market by Treatment, 2020-2027, (USD Million)
    58. Infection Market by End Users, 2020-2027, (USD Million)
    59. Kidney Infection Market by Diagnosis, 2020-2027, (USD Million)
    60. Pacific Kidney Infection Market by Treatment, 2020-2027, (USD Million)
    61. Asia Pacific Kidney Infection Market by End Users, 2020-2027, (USD Million)
    62. (USD Million)
    63. Treatment, 2020-2027, (USD Million)
    64. Infection Market by End Users, 2020-2027, (USD Million)
    65. Market
    66. Global Kidney Infection Market Share, by Treatment 2020
    67. Infection Market Share, by End Users, 2020
    68. Market Share, by Region, 2020
    69. Share, by Country, 2020
    70. Scientific Corp: Segmental Revenue
    71. Revenue
    72. Segmental Revenue
    73. Convergent Laser Technologies. Key Financials
    74. Technologies. Segmental Revenue
    75. Revenue
    76. Inc: Segmental Revenue
    77. Key Financials
    78. Dornier MedTech GmbH: Geographical Revenue'

    Kidney Infection Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study

    Smartphone Motherboard Parts Manufacturing Research